U.S. markets open in 5 hours 27 minutes
  • S&P Futures

    3,376.25
    +24.25 (+0.72%)
     
  • Dow Futures

    27,891.00
    +227.00 (+0.82%)
     
  • Nasdaq Futures

    11,483.75
    +76.50 (+0.67%)
     
  • Russell 2000 Futures

    1,517.60
    +13.20 (+0.88%)
     
  • Crude Oil

    39.98
    -0.24 (-0.60%)
     
  • Gold

    1,902.40
    +6.90 (+0.36%)
     
  • Silver

    23.76
    +0.27 (+1.15%)
     
  • EUR/USD

    1.1737
    +0.0011 (+0.09%)
     
  • 10-Yr Bond

    0.6770
    0.0000 (0.00%)
     
  • Vix

    25.74
    -0.53 (-2.02%)
     
  • GBP/USD

    1.2884
    -0.0037 (-0.28%)
     
  • USD/JPY

    105.5400
    +0.1100 (+0.10%)
     
  • BTC-USD

    10,862.48
    +66.45 (+0.62%)
     
  • CMC Crypto 200

    224.62
    +3.22 (+1.46%)
     
  • FTSE 100

    5,913.08
    +46.98 (+0.80%)
     
  • Nikkei 225

    23,184.93
    -0.19 (-0.00%)
     

'Halftime Report' Traders Weigh In On Under Armour, Ross Stores And More

Craig Jones

Stephanie Link spoke on CNBC's "Fast Money Halftime Report" about Under Armour Inc (NYSE: UAA). She said this is not a stock to own in this environment, but if the management can turn around the company, it could have a lot of earnings power.

Josh Brown would buy both iShares NASDAQ Biotechnology Index (NASDAQ: IBB) and SPDR S&P Biotech (NYSE: XBI) in equal amounts. IBB is going to do better in a runaway bull market for biotech, while XBI is going to outperform in a more nuanced environment, explained Brown.

Michael Farr said Ross Stores, Inc. (NASDAQ: ROST) has a challenging environment going forward. It's still trying to open stores. He still has a position in the name, but it's not a big one. He has trimmed it already.

See more from Benzinga

© 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.